Suppr超能文献

[肝移植受者晚期死亡原因分析]

[Analysis of causes of late mortality in liver transplant recipients].

作者信息

Pan Cheng, Jain Ashok, Fung John J

机构信息

The Department of Transplantation Surgery, Tianjin First Central Hospital, Tianjin 300192, China.

出版信息

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004 Sep;16(9):547-51.

Abstract

OBJECTIVE

To evaluate the cause of late mortality in liver transplant recipients, and to study the prevention and management of these complications.

METHODS

Two thousand nine hundred and forty patients who underwent liver transplantation at University of Pittsburgh and survived more than 1 year between February 1981 and April 1998 were included in this study. Cause of death, and other relative factors were analyzed.

RESULTS

The rate of death dramatically decreased from 20.4% to 1.9% during that 10 years (1981-1991). Eight hundred and seventeen patients who survived more than 1 year had died during the follow-up period. The causes of death were malignant tumor (20.7%), cardiovascular complication (11.4%), infection (11.3%), and respiratory system complications (9.4%). Following the change in the immunosuppression protocol (1981-1986 was cyclosporin-A, 1986-1990 was OKT3, 1991-1998 was FK506), the 1-year death rate, 5-year death rate, and 10-year death rate were constantly decreased postoperatively. Patients of 3-18-year old group had the lowest mortality rate, while that of 19-60-year old group had the highest mortality rate. The patients who received liver transplantation because hepatic carcinoma or fulminant hepatic failure had the highest mortality after the operation. Mortality of the patients who received liver transplantation because of alcoholic cirrhosis increased gradually year by year.

CONCLUSION

Malignant tumor, cardiovascular complication, infection and respiratory system complications are the most common causes of late mortality after liver transplantation. Early diagnosis and treatment can improve the survival rate.

摘要

目的

评估肝移植受者晚期死亡的原因,并研究这些并发症的预防和管理措施。

方法

本研究纳入了1981年2月至1998年4月在匹兹堡大学接受肝移植且存活超过1年的2940例患者。分析死亡原因及其他相关因素。

结果

在那10年(1981 - 1991年)期间,死亡率从20.4%急剧下降至1.9%。817例存活超过1年的患者在随访期间死亡。死亡原因包括恶性肿瘤(20.7%)、心血管并发症(11.4%)、感染(11.3%)和呼吸系统并发症(9.4%)。随着免疫抑制方案的改变(1981 - 1986年为环孢素A,1986 - 1990年为OKT3,1991 - 1998年为FK506),术后1年死亡率、5年死亡率和10年死亡率持续下降。3 - 18岁年龄组患者的死亡率最低,而19 - 60岁年龄组的死亡率最高。因肝癌或暴发性肝衰竭接受肝移植的患者术后死亡率最高。因酒精性肝硬化接受肝移植的患者死亡率逐年逐渐上升。

结论

恶性肿瘤、心血管并发症、感染和呼吸系统并发症是肝移植后晚期死亡最常见的原因。早期诊断和治疗可提高生存率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验